Pediatrix Medical Group, Inc. (NYSE:MD) Receives Average Recommendation of “Hold” from Brokerages
by Sarita Garza · The Markets DailyPediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) has been assigned an average recommendation of “Hold” from the seven research firms that are currently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $19.80.
MD has been the topic of several analyst reports. Jefferies Financial Group raised Pediatrix Medical Group to a “strong-buy” rating in a research report on Thursday, March 12th. Deutsche Bank Aktiengesellschaft set a $19.00 target price on Pediatrix Medical Group in a report on Friday, February 20th. Truist Financial lowered their price target on Pediatrix Medical Group from $24.00 to $21.00 and set a “hold” rating on the stock in a report on Thursday, February 19th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Friday, March 27th. Finally, UBS Group reduced their price objective on Pediatrix Medical Group from $23.00 to $22.00 and set a “neutral” rating for the company in a report on Tuesday, February 24th.
Check Out Our Latest Stock Analysis on Pediatrix Medical Group
Pediatrix Medical Group Stock Up 2.4%
Shares of Pediatrix Medical Group stock opened at $21.19 on Friday. The company has a 50-day simple moving average of $20.47 and a two-hundred day simple moving average of $20.35. The stock has a market capitalization of $1.76 billion, a PE ratio of 10.92 and a beta of 0.72. Pediatrix Medical Group has a 52-week low of $11.84 and a 52-week high of $24.99. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.66 and a current ratio of 1.66.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last posted its quarterly earnings results on Thursday, February 19th. The company reported $0.50 EPS for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.03). The firm had revenue of $493.77 million for the quarter, compared to analysts’ expectations of $486.23 million. Pediatrix Medical Group had a net margin of 8.64% and a return on equity of 19.59%. The company’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.51 EPS. On average, analysts anticipate that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.
Institutional Trading of Pediatrix Medical Group
Large investors have recently made changes to their positions in the stock. Rockefeller Capital Management L.P. raised its holdings in shares of Pediatrix Medical Group by 814.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 594,351 shares of the company’s stock valued at $12,713,000 after purchasing an additional 529,367 shares during the last quarter. Invesco Ltd. boosted its holdings in Pediatrix Medical Group by 24.4% in the fourth quarter. Invesco Ltd. now owns 1,090,655 shares of the company’s stock worth $23,329,000 after purchasing an additional 213,636 shares during the last quarter. State of Tennessee Department of Treasury grew its position in Pediatrix Medical Group by 2.8% in the 4th quarter. State of Tennessee Department of Treasury now owns 46,016 shares of the company’s stock worth $984,000 after purchasing an additional 1,246 shares during the period. EP Wealth Advisors LLC bought a new stake in Pediatrix Medical Group in the 4th quarter worth approximately $472,000. Finally, Mackenzie Financial Corp raised its stake in Pediatrix Medical Group by 35.7% during the 4th quarter. Mackenzie Financial Corp now owns 55,150 shares of the company’s stock valued at $1,201,000 after buying an additional 14,502 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors.
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.
Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.